Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sonoma Pharmaceuticals Inc
(NQ:
SNOA
)
0.1560
+0.0029 (+1.89%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Sonoma Pharmaceuticals Inc
< Previous
1
2
Next >
Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South Africa
March 30, 2022
From
Sonoma Pharmaceuticals, Inc.
Via
Business Wire
Sonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial Results
February 11, 2022
From
Sonoma Pharmaceuticals, Inc.
Via
Business Wire
Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China
January 20, 2022
From
Sonoma Pharmaceuticals, Inc.
Via
Business Wire
Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022
January 05, 2022
From
Sonoma Pharmaceuticals, Inc.
Via
Business Wire
Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results
November 15, 2021
From
Sonoma Pharmaceuticals, Inc.
Via
Business Wire
Sonoma Pharmaceuticals and Dyamed Biotech Announce Expanded Long-Term Partnership for New Territories and Products in Southeast Asia
November 09, 2021
From
Sonoma Pharmaceuticals, Inc.
Via
Business Wire
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Been Approved by the Australia TGA with a 15 Second SARS-CoV-2 (COVID-19) Kill Time
October 15, 2021
From
Sonoma Pharmaceuticals, Inc.
Via
Business Wire
Sonoma Pharmaceuticals Launches Its First Over-the-Counter Products in the U.S. on Amazon and a New Consumer-Focused Product on Amazon in Europe
September 28, 2021
From
Sonoma Pharmaceuticals, Inc.
Via
Business Wire
Sonoma Pharmaceuticals Announces Expanded Dental Care Line with a New Product for Professional Care in the U.S. and a New Product for Professional and Consumer Care in Switzerland
August 19, 2021
From
Sonoma Pharmaceuticals, Inc.
Via
Business Wire
Sonoma Pharmaceuticals Reports First Quarter 2022 Financial Results
August 16, 2021
From
Sonoma Pharmaceuticals, Inc.
Via
Business Wire
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2021 Financial Results
July 14, 2021
From
Sonoma Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.